A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 4 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ENTYVIO (VEDOLIZUMAB IV) IN THE TREATMENT OF CHRONIC POUCHITIS (EARNEST)

Registry ID

VEDOLIZUMAB-4004

Source registry

HEALTH_CANADA

Status

Closed

Phase

PHASE4

Study type

INTERVENTIONAL

Sponsor

TAKEDA DEVELOPMENT CENTER AMERICAS INC

Start date

2017-01-18

Completion date

2021-02-09

Last update

2016-05-05

Conditions

• POUCHITIS

Related clinical trials

• A COMBINED PHASE 2/3 12-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY INVESTIGATING THE EFFICACY OF AMT-101 IN SUBJECTS WITH CHRONIC ANTIBIOTIC-RESISTANT POUCHITIS

View on source registry